CY
NASDAQ · CYAD
Celyad Oncology S.A.
Healthcare · Biotechnology
$0.47
Down-$0.07 (-12.96%)
Updated Aug 24, 2026, 5:50 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 14.24M
- P/E ratio
- -1.19
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 49K
- Avg. volume
- 18.59K
Price performance
CYAD price history
1M range · 0 trading sessions · Daily adjusted prices
CYAD does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest CYAD news
The latest Smart Investors Daily articles mentioning CYAD.
Stock researchResearch & News · SEC Filings
Loading stock research…
